+499.5%
MRNA vs CRL
+78.8%
+420.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CRL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.7% | -0.6% | -1.0% |
| 7D | +5.5% | -1.0% | +6.5% | +6.0% |
| 30D | +158.7% | +10.7% | +148.1% | +147.5% |
| 3M | +182.1% | +55.3% | +126.8% | +124.8% |
| 6M | +151.8% | +60.7% | +91.2% | +94.9% |
| YTD | +393.6% | +44.6% | +348.9% | +311.0% |
| 1Y | +499.5% | +77.7% | +421.7% | +329.2% |
| All | +499.5% | +78.8% | +420.6% | +329.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CRL.
Daily Out/Under-Performance
Portfolio return minus CRL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling